The Effect of Grape Seed Extract on Cardiovascular Risk Markers: A Meta-Analysis of Randomized Controlled Trials

Abstract Recent animal studies have suggested that grape seed extract has beneficial effects on the cardiovascular system. Randomized trials in human beings have yielded conflicting results. The objective of this systematic review was to assess the effect of grape seed extract on changes in blood pr...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Dietetic Association 2011-08, Vol.111 (8), p.1173-1181
Main Authors: Feringa, Harm H.H., MD, PhD, Laskey, Dayne A., PharmD, Dickson, Justine E., PharmD, Coleman, Craig I., PharmD
Format: Article
Language:English
Subjects:
Biological and medical sciences
Biomarkers - blood
Blood Pressure - drug effects
C-Reactive Protein - drug effects
Cardiology. Vascular system
Cardiovascular disease
Cardiovascular Diseases - blood
Cardiovascular Diseases - drug therapy
Cardiovascular Diseases - epidemiology
Clinical trials
Coronary heart disease
Effects
Feeding. Feeding behavior
Fundamental and applied biological sciences. Psychology
Gastroenterology and Hepatology
Grape Seed Extract - pharmacology
Grape Seed Extract - therapeutic use
Health risk assessment
Heart
Heart Rate - drug effects
Humans
Internal Medicine
Lipid Metabolism - drug effects
Medical sciences
Meta-analysis
Oils & fats
Randomized Controlled Trials as Topic
Treatment Outcome
Vertebrates: anatomy and physiology, studies on body, several organs or systems
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Recent animal studies have suggested that grape seed extract has beneficial effects on the cardiovascular system. Randomized trials in human beings have yielded conflicting results. The objective of this systematic review was to assess the effect of grape seed extract on changes in blood pressure, heart rate, lipid levels, and C-reactive protein (CRP) levels. We searched MEDLINE (January 1, 1950, through October 31, 2010), Agricola (January 1, 1970, through October 31, 2010), Scopus (January 1, 1996, through October 31, 2010), and the Cochrane Central Register of Controlled Trials (through October 31, 2010) for randomized controlled trials in human beings of grape seed extract reporting efficacy data on at least one of the following end points: systolic or diastolic blood pressure, heart rate, total cholesterol, low-density or high-density lipoprotein cholesterol, triglycerides, or CRP. A manual search of references from primary and review articles was performed to identify additional relevant trials. For all endpoints except CRP, the mean change in each parameter from baseline was treated as a continuous variable and the effect size was calculated as the weighted mean difference between the means in the grape seed extract and control groups. Data on CRP were pooled as a standardized mean difference. Nine randomized, controlled trials (N=390) met the inclusion criteria, and a meta-analysis was conducted. Upon meta-analysis, grape seed extract significantly lowered systolic blood pressure (weighted mean difference −1.54 mm Hg (95% confidence interval −2.85 to −0.22, P =0.02]), and heart rate (weighted mean difference −1.42 bpm (95% confidence interval −2.50 to −0.34, P =0.01]). No significant effect on diastolic blood pressure, lipid levels, or CRP was found. No statistical heterogeneity was observed for any analysis ( I2
ISSN:0002-8223
2212-2672
1878-3570
2212-2680
DOI:10.1016/j.jada.2011.05.015